Carregant...
ACS Chemical Neuroscience Molecule Spotlight on Fanapt
[Image: see text] The new mixed dopamaine D(2)/serotonin 5-HT(2A) antagonist, Fanapt (iloperidone), was approved by the FDA on May 6th, 2009 for the treatment of schizophrenia in adults.
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Chemical Society
2010
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3368683/ https://ncbi.nlm.nih.gov/pubmed/22778835 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn100024g |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|